Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,868 across all filing types
Latest filing 2015-03-17 Regulatory Filings
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos regains rights to GLPG1690, announces end of alliance with Janssen
Regulatory Filings Classification · 95% confidence The document is a press release dated March 17, 2015, announcing the termination of an alliance between Galapagos and Janssen and the regaining of full rights to the drug candidate GLPG1690. It details clinical progress (Phase 1 completion, preparation for Phase 2 study in IPF) and provides background information on the drug, the disease (IPF), and the company (Galapagos). This content structure—a formal announcement of a significant business/pipeline event, often released outside of standard quarterly/annual reporting cycles—is characteristic of a general corporate announcement. Since it is not a full financial report (10-K, IR), a specific earnings release (ER), a management discussion (MDA), or a proxy statement (DEF 14A), and it is not merely announcing the publication of another report (RPA), the most appropriate classification is the general 'Regulatory Filings' fallback category (RNS), as it is a material corporate event disclosure.
2015-03-17 English
Galapagos krijgt rechten terug voor GLPG1690, kondigt het beëindigen van alliantie met Janssen aan
M&A Activity Classification · 99% confidence The document is dated March 17, 2015, and is titled 'Gereglementeerde informatie' (Regulated information). The content announces a significant business event: the termination of an alliance with Janssen and the regaining of full rights to the drug candidate GLPG1690, along with plans for a Phase 2 clinical study. This type of announcement, detailing strategic corporate actions, pipeline updates, and significant business developments, is characteristic of a general regulatory announcement or press release that doesn't fit the specific financial reporting categories (like 10-K, ER, or IR). Since it is a formal announcement of a material event, and it is not a specific financial report, dividend notice, or management change, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements.
2015-03-17 Dutch
Galapagos to be included in Amsterdam Midcap Index
Regulatory Filings Classification · 95% confidence The document is a short press release from Galapagos NV announcing its inclusion in the Amsterdam Midcap Index, effective March 23, 2015, following Euronext's annual review. It contains company background, pipeline updates, and contact information. It is not a full financial report (10-K or IR), an earnings release (ER), a proxy statement (DEF 14A), or a formal audit report (AR). Since it is a specific, non-financial regulatory/exchange announcement (index inclusion) that doesn't fit the other specific categories (like DIRS, DIV, CAP, etc.), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous official announcements not covered elsewhere. Given the short length and announcement nature, it is not a detailed presentation (IP) or management discussion (MDA).
2015-03-06 English
Galapagos to be included in Amsterdam Midcap Index
Regulatory Filings Classification · 95% confidence The document is a short press release dated March 6, 2015, announcing that Galapagos NV will be included in the Amsterdam Midcap Index, effective March 23, 2015. It provides company background, pipeline updates, and contact information. This type of announcement, which is a specific corporate action/news update that doesn't fit the primary financial report categories (10-K, IR, ER) or specific corporate governance/insider trading categories, is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the index inclusion is viewed as a significant market event. Given the options, RNS serves as the best general regulatory announcement fallback for non-standard news releases. It is too short and specific to be an Annual Report (10-K) or an Interim Report (IR). It is not a dividend notice (DIV), management change (MANG), or earnings release (ER). Therefore, RNS is the most appropriate classification for this general regulatory announcement.
2015-03-06 English
Galapagos reports 2014 financial results
Earnings Release Classification · 96% confidence The document is titled "Galapagos reports 2014 financial results" and presents key financial figures, management guidance for 2015, detailed operational highlights, and a summary of the full year 2014 performance. It explicitly mentions that the company is finalizing its financial statements and expects to publish its "fully audited Annual Financial Report for the full year 2014 on or around 27 March 2015." Although this document is a press release announcing the results, its content is a comprehensive summary of the full annual performance, which strongly aligns with the scope of an Annual Report (10-K) or a detailed Earnings Release (ER) that often precedes the 10-K. Given the depth of financial tables and operational review covering the entire fiscal year, it functions as the primary disclosure of annual results. However, since it is a press release announcing the results and explicitly states the *Annual Financial Report* will be published later, it is most accurately classified as an Earnings Release (ER) which provides the key highlights and financial summary before the formal 10-K filing. The length (over 30k characters) also supports it being more than just a brief announcement (RPA). FY 2014
2015-03-06 English
Galapagos reports 2014 financial results
Earnings Release Classification · 98% confidence The document is titled "Galapagos maakt financiële resultaten 2014 bekend" (Galapagos announces financial results 2014) and contains key financial highlights (revenue, net profit, cash position) for the year 2014, along with management expectations for 2015. It includes a detailed table of consolidated key figures comparing 2014 and 2013. This content strongly indicates a formal announcement of periodic financial results. Although it discusses the upcoming full 'Financieel Jaarverslag 2014' (Annual Financial Report), the document itself is the initial release summarizing these results. This aligns perfectly with the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is not the full 10-K, nor is it a transcript (CT) or a general factsheet (FS). FY 2014
2015-03-06 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.